Asthma and COVID-19: What do we know now

被引：19
|
作者：
Hughes-Visentin, Alexzandra [1 ]
Paul, Anthea B. Mahesan [2 ]
机构：
[1] Univ Ottawa, Fac Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
[2] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada
来源：
CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE | 2020年 / 14卷
关键词：
COVID-19; asthma; respiratory; biologics; treatment; corticosteroids; CORONAVIRUS DISEASE 2019; CLINICAL CHARACTERISTICS; PNEUMONIA; SARS-COV-2; NEBULIZER; WUHAN; RISK;
D O I：
10.1177/1179548420966242
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).
引用
收藏
页数：7
相关论文
共 50 条
  • [31] COVID-19 and Hematology—What Do We Know So Far?
    Harshwardhan Khandait
    Garima Gandotra
    Sonali Sachdeva
    Courtney A. Kramer
    Derek Nye
    Reshma Golamari
    Rohit Jain
    SN Comprehensive Clinical Medicine, 2020, 2 (12) : 2631 - 2636
  • [32] Covid-19: What do we know about omicron sublineages?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 376
  • [33] COVID-19 and the liver: What do we know so far?
    Prashant Nasa
    George Alexander
    World Journal of Hepatology, 2021, 13 (05) : 522 - 532
  • [34] Elective procedures in times of COVID-19: ?What do we know?
    Ensuncho, Cesar
    ARCHIVOS DE MEDICINA, 2020, 20 (02): : 513 - 517
  • [35] COVID-19 and diabetes: What do we know so far?
    Gangadaran, Prakash
    Padinjarathil, Himabindu
    Rajendran, Shri Hari Subhashri
    Jogalekar, Manasi P.
    Hong, Chae Moon
    Aruchamy, Baladhandapani
    Rajendran, Uma Maheswari
    Gurunagarajan, Sridharan
    Krishnan, Anand
    Ramani, Prasanna
    Subramanian, Kavimani
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (15) : 1330 - 1334
  • [36] COVID-19 and the liver: What do we know so far?
    Nasa, Prashant
    Alexander, George
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (05) : 522 - 532
  • [37] COVID-19 and Myocarditis: What Do We Know So Far?
    Pirzada, Ashar
    Mokhtar, Ahmed T.
    Moeller, Andrew D.
    CJC OPEN, 2020, 2 (04) : 278 - 285
  • [38] COVID-19 vaccines: what do we know so far?
    Dhillon, Paraminder
    Altmann, Daniel
    Male, Victoria
    FEBS JOURNAL, 2021, 288 (17) : 4996 - 5009
  • [39] Breast Milk and COVID-19: What Do We Know? COMMENT
    Kimberlin, David W.
    Puopolo, Karen M.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (01) : 131 - 132
  • [40] COVID-19 and the gastrointestinal tract: what do we already know?
    Machado de Almeida, Joana Ferro
    Chehter, Ethel Zimberg
    EINSTEIN-SAO PAULO, 2020, 18 : eRW5909
12345